BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5917401)

  • 21. Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course.
    West CD; McAdams AJ
    Nephron; 1970; 7(3):193-202. PubMed ID: 5442623
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of immunosuppressive therapy in chronic nephropathy with special reference to biopsy findings].
    Gömöri P; Beregi E; Varga S
    Z Gesamte Inn Med; 1972 Nov; 27(22):976-80. PubMed ID: 4649658
    [No Abstract]   [Full Text] [Related]  

  • 23. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunotherapy mechanisms in glomerulonephritis].
    Polci R; Feriozzi S
    G Ital Nefrol; 2011; 28(6):612-21. PubMed ID: 22167612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive therapy.
    Winkelstein A; Segel D; Stolzer BL; Fogel M; Shadduck RK; Lewis M
    Am J Med Sci; 1973 Feb; 265(2):92-108. PubMed ID: 4736193
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nephrotic syndrome due to primary renal disease. Study of therapeutic response (author's transl)].
    Casado S; Ruilope LM; Oliva H; Hernando L
    An Esp Pediatr; 1974; 7(2):124-30. PubMed ID: 4849232
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppressive therapy. 2.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(6):281-6. PubMed ID: 4556903
    [No Abstract]   [Full Text] [Related]  

  • 30. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
    Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppressive agents in the treatment of the nephrotic syndrome and glomerulonephritis in children.
    Cameron JS
    Paediatrician; 1979; 8(5-6):364-77. PubMed ID: 392408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute leukaemia during immunosuppressive therapy of glomerulonephritis.
    Uszyński L; Szczecińska M; Dudkiewicz H; Sliwowski A
    Mater Med Pol; 1978; 10(3):226-7. PubMed ID: 281591
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial.
    Booth LJ; Aber GM
    Lancet; 1970 Nov; 2(7681):1010-3. PubMed ID: 4098045
    [No Abstract]   [Full Text] [Related]  

  • 36. [On immunosuppressive therapy of primary nephrotic syndrome in the pediatric age].
    Varese LA
    Minerva Pediatr; 1971 Dec; 23(50):2090-102. PubMed ID: 5135685
    [No Abstract]   [Full Text] [Related]  

  • 37. [QImmunosuppressive therapy of glomerulonephritis].
    Asamer H; Dittrich M
    Med Klin; 1970 May; 65(22):1076-81. PubMed ID: 5521134
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of the nephrotic syndrome.
    Linshaw MA; Gruskin AB
    Clin Pediatr (Phila); 1974 Jan; 13(1):45-51. PubMed ID: 4588668
    [No Abstract]   [Full Text] [Related]  

  • 39. A multicenter study of Consupren (cyclosporine) versus cyclophosphamide in chronic glomerulonephritis.
    Matl I; Matousovic K; Lánská V
    Transplant Proc; 1996 Dec; 28(6):3149-51. PubMed ID: 8962220
    [No Abstract]   [Full Text] [Related]  

  • 40. [Steroid and immunosuppressive therapy in primary glomerular nephropathy (glomerulonephritis) in adults. Clinical and nephrobioptic study].
    Bonomini V; Mioli V; Albertazzi A; Vangelista A
    Minerva Nefrol; 1969; 16(2):103-19. PubMed ID: 5398499
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.